Interleukin 15: Its role in intestinal inflammation

Gut

Volumn 55, Issue 4, 2006, Pages 444-445

  Van Heel, D A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAX IL15; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; MONOCLONAL ANTIBODY;

CELIAC DISEASE; CLINICAL TRIAL; CROHN DISEASE; DRUG MECHANISM; DRUG TOLERABILITY; ENTERITIS; HUMAN; IMMUNOGLOBULIN PRODUCTION; INTESTINE CELL; INTESTINE EPITHELIUM CELL; LEUKOCYTE ACTIVATION; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

CELIAC DISEASE; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-15; LEUKOCYTES;

EID: 33645120637     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.079335     Document Type: Note

References (20)

1. Burton JD, Bamford RN, Peters C, et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A 1994;91:4935-9.
2. Carson WE, Giri JG, Lindemann MJ, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994;180:1395-403.
3. Reinecker HC, MacDermott RP, Mirau S, et al. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996;111:1706-13.
4. Ebert EC. Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology 1998;115:1439-45.
5. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000;191:771-80.
6. Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998;9:669-76.
7. Kirman I, Nielsen OH. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am J Gastroenterol 1996;91:1789-94.
8. Sakai T, Kusugami K, Nishimura H, et al. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 1998;114:1237-43.
9. Liu Z, Geboes K, Colpaert S, et al. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol 2000;164:3608-15.
10. Yoshihara K, Yajima T, Kubo C, et al. The role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 2006;55:334-41.
11. Mention JJ, Ben Ahmed M, Begue B, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003;125:730-45.
12. Maiuri L, Ciacci C, Auricchio S, et al. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000;119:996-1006.
13. Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003;362:30-7.
14. Hue S, Mention JJ, Monteiro RC, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367-77.
15. Meresse B, Chen Z, Ciszewski C, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004;21:357-66.
16. Kinoshita N, Hiroi T, Ohta N, et al. Autocrine IL15 mediates intestinal epithelial cell death via the activation of neighboring intraepithelial NK cells. J Immunol 2002;169:6187-92.
17. Di Sabatino A, Ciccocioppo R, Cupelli F, et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006;55:469-77.
18. Ohta N, Hiroi T, Kweon MN, et al. IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation. J Immunol 2002;169:460-8.
19. Sturgess R, Day P, Ellis HJ, et al. Wheat peptide challenge in coeliac disease. Lancet 1994;343:758-61.
20. Baslund B, Tvede N, Danneskiold-Samsoe B, et al. Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study. Arthritis Rheum 2005;52:2686-92.